Blog
RSS FeedPosted by Michael Wonder on 03 Jan 2023
Hansa Biopharma announces positive reimbursement decision for Idefirix (imlifidase) in the Czech Republic
2 January 2023 - Idefirix is the first and only product approved for use in highly sensitised patients waiting for a ...